ArticleRevista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)2025
White matter hyperintensities and their role in major depressive episodes: a cross-sectional study in adults under 65.
Article in Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02051413 (Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder
Who cites it
1 citing paper in PubMed.
- It is unlikely that major depression severity correlates with white matter lesion volume.Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveWhite matter hyperintensities (WMH) are associated with major depressive episodes (MDE) in individuals aged 65 and older. WMH are prevalent in adults under 65, yet the association between their volume and MDE in this population remains uncertain. This study aimed to assess the association of WMH volume with MDE and its severity in patients aged < 65.
methodsCross-sectional study (ancillary to clinical trial NCT02051413) of subjects under the age of 65. Overall, 69 patients with MDE and 32 healthy controls (HCs) were included. Severity was assessed with the Hamilton Rating Scale (HRS) and WMH were quantified by two experts. Post-hoc mediation analyses were conducted if associations were found between independent variables and WMH.
resultsMean age was 34.5 (12.4) years. There was no difference in WMH between patients and HCs. Higher WMH volumes were observed in extremely severe MDE (2,170.2 [3,767.9] mm3 vs. 416.6 [594.9] mm3 [r = 0.21; p < 0.05]), which completely mediated the effect of age on severity.
conclusionsIn a sample of adults under 65, this study failed to identify higher WMH volume in patients with MDE compared to HCs. However, WMH may act as a mediator of the association between age and MDE severity. This finding suggests that WMH could contribute to more severe depression in late life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.